{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:21:04Z","timestamp":1758637264457,"version":"3.41.2"},"reference-count":62,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Sports Med"],"published-print":{"date-parts":[[2005,4]]},"abstract":"<jats:p>Performance enhancing agents are prohibited in athletic competition so that only athletic skills can determine outcomes. Modafinil is a novel non-addicting psychostimulant approved for treatment of narcolepsy. Does its use, especially for medical indications, violate the Olympic Movement Anti-Doping Code? This is discussed with reference to a current high profile case.<\/jats:p>","DOI":"10.1136\/bjsm.2004.016303","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T13:22:49Z","timestamp":1111756969000},"page":"241-244","source":"Crossref","is-referenced-by-count":21,"title":["Modafinil in sports: ethical considerations"],"prefix":"10.1136","volume":"39","author":[{"given":"K R","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2005,3,25]]},"reference":[{"key":"2025080115114676000_39.4.241.1","unstructured":"International Olympic Committee. Olympic Creed. http:\/\/www.janecky.com\/olympic\/creed.html (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.2","unstructured":"International Olympic Committee. Olympic Oath. http:\/\/www.janecky.com\/olympic\/oath.html (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.3","unstructured":"International Olympic Committee. Olympic Motto. http:\/\/www.janecky.com\/olympic\/motto (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.4","first-page":"97","volume":"45","year":"2003","journal-title":"Vet Hum Toxicol"},{"key":"2025080115114676000_39.4.241.5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/clinchem\/43.7.1262","volume":"43","year":"1997","journal-title":"Clin Chem"},{"key":"2025080115114676000_39.4.241.6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/clinchem\/43.7.1110","volume":"43","year":"1997","journal-title":"Clin Chem"},{"key":"2025080115114676000_39.4.241.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0633-z"},{"key":"2025080115114676000_39.4.241.8","unstructured":"International Olympic Committee. Olympic Movement Anti-Doping Code. Lausanne, Switzerland: International Olympic Committee, 1999."},{"key":"2025080115114676000_39.4.241.9","unstructured":"International Olympic Committee. Olympic Movement Anti-Doping Code Appendix A (in force as of 1 January 2003). http:\/\/www.cces.ca\/WADA-PUB-ProhibitedList2003-E.pdf (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.10","unstructured":"International Olympic Committee. Olympic Charter (in force as of 4 July 2003). http:\/\/multimedia.olympic.org\/pdf\/en_report_122.pdf (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(96)80207-4"},{"key":"2025080115114676000_39.4.241.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(00)00031-9"},{"key":"2025080115114676000_39.4.241.13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.6.2192"},{"key":"2025080115114676000_39.4.241.14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4088\/JCP.v61n0510","volume":"61","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"2025080115114676000_39.4.241.15","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104910.75206.b9"},{"key":"2025080115114676000_39.4.241.16","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317040-00002"},{"key":"2025080115114676000_39.4.241.17","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000037481.08283.51"},{"key":"2025080115114676000_39.4.241.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4637.2003.03014.x"},{"key":"2025080115114676000_39.4.241.19","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200203000-00010"},{"key":"2025080115114676000_39.4.241.20","doi-asserted-by":"publisher","DOI":"10.1177\/088307380201700303"},{"key":"2025080115114676000_39.4.241.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(03)00148-6"},{"key":"2025080115114676000_39.4.241.22","first-page":"167","volume":"17","year":"2002","journal-title":"Eur Psychiatry"},{"key":"2025080115114676000_39.4.241.23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-002-1250-8","volume":"165","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"2025080115114676000_39.4.241.24","first-page":"301","volume":"25","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"2025080115114676000_39.4.241.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2003.11.003"},{"key":"2025080115114676000_39.4.241.26","doi-asserted-by":"publisher","DOI":"10.1007\/BF02247379"},{"key":"2025080115114676000_39.4.241.27","doi-asserted-by":"publisher","DOI":"10.1177\/026988110001400107"},{"key":"2025080115114676000_39.4.241.28","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.11.1947"},{"key":"2025080115114676000_39.4.241.29","first-page":"328","volume":"103","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"2025080115114676000_39.4.241.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00962-2"},{"key":"2025080115114676000_39.4.241.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.14128"},{"key":"2025080115114676000_39.4.241.32","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","volume":"20","year":"2000","journal-title":"J Neurosci"},{"key":"2025080115114676000_39.4.241.33","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00182-3"},{"key":"2025080115114676000_39.4.241.34","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199709080-00016"},{"key":"2025080115114676000_39.4.241.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00085-2"},{"key":"2025080115114676000_39.4.241.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2004.03243.x"},{"key":"2025080115114676000_39.4.241.37","unstructured":"Ramsak B. I can only be Kelli White. http:\/\/www.iaaf.org\/WCH03\/news\/Kind=2\/newsld-22919.html (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.38","unstructured":"Nichols P. White tests positive for stimulant. http:\/\/www.sport\/guardian.co.uk\/athletics\/story\/0,10082,10032573,00.html (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.39","unstructured":"BBC Sport. White under investigation. http:\/\/news.bbc.co.uk\/sport1\/hi\/athletics\/world_athletics-2003\/3194041.stm (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.40","unstructured":"Nichols P. White\u2019s second positive only serves to muddy waters. http:\/\/timesonline.co.uk\/printFriendly\/0,,1-7817-891835,00.html (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.41","doi-asserted-by":"crossref","unstructured":"Patrick D. IAAF probing Kelli White drug sample. http:\/\/usatoday.com\/sports\/olympics\/summer\/track\/2003-08-30-white-doping-probe_x.htm (accessed 27 March 2004).","DOI":"10.1016\/S0045-8732(04)80012-3"},{"key":"2025080115114676000_39.4.241.42","unstructured":"IAAF Communication on the Kelli White Case 3 September 2003. http:\/\/www.iaaf.org\/news\/Kind=512\/newsld=23089.html (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.43","unstructured":"IAAF Communication on the Kelli White Case 9 September 2003. http:\/\/www.iaaf.org\/news\/Kind=512\/newsld=23144.html (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.44","doi-asserted-by":"publisher","DOI":"10.1016\/s1389-9457(02)00240-x"},{"key":"2025080115114676000_39.4.241.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1995.tb00295.x"},{"key":"2025080115114676000_39.4.241.46","first-page":"277","volume":"16","year":"2003","journal-title":"Space Med Med Eng (Beijing)"},{"key":"2025080115114676000_39.4.241.47","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(00)00081-2"},{"key":"2025080115114676000_39.4.241.48","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1508-9"},{"key":"2025080115114676000_39.4.241.49","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-2457(03)00203-7"},{"key":"2025080115114676000_39.4.241.50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2869.2000.00177.x"},{"key":"2025080115114676000_39.4.241.51","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genom.4.070802.110432"},{"key":"2025080115114676000_39.4.241.52","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(01)00161-7"},{"key":"2025080115114676000_39.4.241.53","unstructured":"World Anti-Doping Code (in force as of March 2003). http:\/\/www.wada-ama.org\/docs\/web\/statutes_harmonization\/code\/cod_v3.pdf ) (accessed 27 March 2004)."},{"key":"2025080115114676000_39.4.241.54","unstructured":"IAAF. Control of drug abuse. http:\/\/www.tcaa.com.hk\/tf\/tf_download\/iaaf\/9899\/hb9899_3.pdf (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.55","unstructured":"IAAF. Procedural Guidelines for Doping Control. http:\/\/www.sportspro.it\/doping\/regolamenti\/RegIaaf.pdf (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.56","unstructured":"O\u2019Brien K. Sympathy but no medal for Romanian gymnast. http:\/\/www.abc.net.au\/7:30\/s192661.htm (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.57","unstructured":"BBC Sport. US officials admit drug tests. http:\/\/news.bbc.co.uk\/sport1\/hi\/athletics\/3358253.stm (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.58","unstructured":"CBC Sports Online. IAAF official scoffs at \u201cnarcolepsy epidemic. \u201d http:\/\/www.cbc.ca\/pcgi-bin\/templates\/sportsViewcgi?\/news\/2003\/10\/27\/Sports\/modafinil_ljungvist031027.htm (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.59","unstructured":"ABCsportonline. Two-year bans introduced for Modafinil use. http:\/\/www.abc.net.au\/sport\/contents\/s1034581.htm (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.60","unstructured":"Gloster R. USOC confirms Toth\u2019s THG, modafinil test. http:\/\/www.usatoday.com\/sports\/olympics\/summer\/2004-02-16-usoc_x.htm (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.61","unstructured":"BBC Sport. The THG scandal explained. http:\/\/www.news.bbc.co.uk\/sport1\/hi\/athletics\/3210876.stm (accessed 4 April 2004)."},{"key":"2025080115114676000_39.4.241.62","unstructured":"Gloster R. U.S. seeks tougher anti-drug standards. http:\/\/www.detnews.com\/2003\/moresports\/0310\/27\/sports-305173.htm (accessed 4 April 2004)."}],"container-title":["British Journal of Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjsm.2004.016303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T22:11:56Z","timestamp":1754086316000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjsm.bmj.com\/lookup\/doi\/10.1136\/bjsm.2004.016303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,25]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,3,25]]},"published-print":{"date-parts":[[2005,4]]}},"alternative-id":["10.1136\/bjsm.2004.016303"],"URL":"https:\/\/doi.org\/10.1136\/bjsm.2004.016303","relation":{},"ISSN":["0306-3674","1473-0480"],"issn-type":[{"type":"print","value":"0306-3674"},{"type":"electronic","value":"1473-0480"}],"subject":[],"published":{"date-parts":[[2005,3,25]]}}}